<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g260" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-257.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
	<a href="../menu.html" class="ui-btn ui-icon-grid ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-224.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-257.html" >Gonococcal Infections</a><span class="carrot"> > </span>
                    <a href="lv-257.html" >Gonococcal Infections Among Children</a><span class="carrot"> > </span>Other Management Considerations
            </div>
            </br><h3 class="sgc-1" id="sigil_toc_id_260">
 Other Management Considerations
</h3>
<p>
 Only parenteral cephalosporins (i.e., ceftriaxone) are recommended&nbsp;for use in children; cefotaxime is approved for gonococcal&nbsp;ophthalmia only. No data are available regarding the use of oral cefixime to treat gonococcal infections in children.
</p>
<p>
 All children found to have gonococcal infections should be evaluated for coinfection with syphilis and
 <i>
  C. trachomatis
 </i>
 . (For a discussion of concerns regarding sexual assault, see Sexual Assault or Abuse of Children.)
</p>

            </div>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

